By InvitationNot Applicable

Reliability and Performance Analysis of the Use of Tissue Flossing for Blood Flow Restriction.

Brazil136 participantsStarted 2024-08-01

Plain-language summary

Blood flow restriction (RFS) is a widely studied technique that combines low-intensity exercise with vascular occlusion, resulting in muscular benefits. However, its application is challenging due to methodological variations and equipment costs. Tissue Flossing (TF) appears as an affordable alternative, but lacks solid scientific evidence.

Who can participate

Age range

18 Years – 30 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals who present one or more of the following characteristics will not be included: * 1 presence of any health condition that contraindicates or prevents exercise; * 2 diabetes and diagnosed high blood pressure; * 3 inflammatory, psychiatric, cardiovascular and/or respiratory rheumatological disease; - -4 being dependent on alcohol, consuming drugs and/or being a smoker; * 5 history of knee surgery (e.g., meniscal repair and ligament reconstruction) or recent lower limb musculoskeletal injury that may impair performance during tests or interventions (e.g., muscle injury, tendinopathy, patellofemoral pain and/or back pain column in the last six months); * 6 use of ergogenic supplements to improve physical performance and/or muscle mass and/or vasoactive medications; * 7 having one or more risk factors predisposing to thromboembolism Exclusion Criteria: * Participants will be excluded from the study if they: * 1 have a health problem that does not allow them to continue; * 2 wish to leave the study; * 3 not sign the consent form

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Occlusion pressures (AOP, 80% and 40% of AOP)

Timeframe: First and Secund Stage - [Time Frame: baseline]

Assessment of arterial flow and diameter

Timeframe: First Stage - [Time Frame: baseline and all subsequent assessments]

Perceptual parameter

Timeframe: First and Secund Stage - [Time Frame: baseline and all subsequent assessments]

Tissue Flossing Assessment

Timeframe: First Stage - [Time Frame: The subsequent assessments]

Weight

Timeframe: First and Secund Stage- [Time Frame: Baseline ]

Height

Timeframe: First and Secund Stage- [Time Frame: Baseline ]

Body Fat

Timeframe: First and Secund Stage- [Time Frame: Baseline ]

Trial details

NCT IDNCT06075901

SponsorPaulista University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12

View on ClinicalTrials.gov More Hypertrophy trials

Plain-language summary

Who can participate

Age range

18 Years – 30 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Occlusion pressures (AOP, 80% and 40% of AOP)

Timeframe: First and Secund Stage - [Time Frame: baseline]

Assessment of arterial flow and diameter

Timeframe: First Stage - [Time Frame: baseline and all subsequent assessments]

Perceptual parameter

Timeframe: First and Secund Stage - [Time Frame: baseline and all subsequent assessments]

Tissue Flossing Assessment

Timeframe: First Stage - [Time Frame: The subsequent assessments]

Weight

Timeframe: First and Secund Stage- [Time Frame: Baseline ]

Height

Timeframe: First and Secund Stage- [Time Frame: Baseline ]

Body Fat

Timeframe: First and Secund Stage- [Time Frame: Baseline ]